KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConvertible DebtCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxMinority InterestNon-Current DebtNon-Current Deferred Tax LiabilityOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityShort-term InvestmentsTotal DebtTotal Liabilities
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Imax (IMAX) Cash & Equivalents (2016 - 2025)

Imax's Cash & Equivalents history spans 16 years, with the latest figure at $151.2 million for Q4 2025.

  • For Q4 2025, Cash & Equivalents rose 50.28% year-over-year to $151.2 million; the TTM value through Dec 2025 reached $151.2 million, up 50.28%, while the annual FY2025 figure was $151.2 million, 50.28% up from the prior year.
  • Cash & Equivalents for Q4 2025 was $151.2 million at Imax, up from $143.1 million in the prior quarter.
  • Across five years, Cash & Equivalents topped out at $267.8 million in Q1 2021 and bottomed at $76.2 million in Q4 2023.
  • The 5-year median for Cash & Equivalents is $106.9 million (2024), against an average of $129.0 million.
  • The largest annual shift saw Cash & Equivalents tumbled 54.85% in 2022 before it soared 50.28% in 2025.
  • A 5-year view of Cash & Equivalents shows it stood at $189.7 million in 2021, then tumbled by 48.66% to $97.4 million in 2022, then dropped by 21.77% to $76.2 million in 2023, then soared by 32.01% to $100.6 million in 2024, then skyrocketed by 50.28% to $151.2 million in 2025.
  • Per Business Quant, the three most recent readings for IMAX's Cash & Equivalents are $151.2 million (Q4 2025), $143.1 million (Q3 2025), and $109.3 million (Q2 2025).